Histone deacetylase inhibitors rescue the impaired memory in terrestrial snails

被引:0
|
作者
Alena B. Zuzina
Alia Kh. Vinarskaya
Pavel M. Balaban
机构
[1] Russian Academy of Sciences,Institute of Higher Nervous Activity and Neurophysiology
来源
关键词
Sodium butyrate; Trichostatin A; Memory reinstatement; Gastropods; Epigenetics;
D O I
暂无
中图分类号
学科分类号
摘要
It is becoming increasingly clear that the long-term plasticity can be regulated via histone modifications. Many studies demonstrated the role of histone acetylation in acquisition, maintenance, and extinction of long-term memory. Nonetheless, the role of histone acetylation in memory reinstatement following its disruption by antimnemonic treatments was not studied in details. In terrestrial snails, we examined effects of the histone deacetylases inhibitors (HDACi) sodium butyrate (NaB) and trichostatin A (TSA) on reinstatement of the context fear memory impaired by antimnemonic agents such as protein synthesis blocker anisomycin (ANI) + reminding or a specific inhibitor of protein-kinase Mζ, zeta inhibitory peptide (ZIP). It was observed that both NaB and TSA applications restored the ANI-impaired context memory regardless of memory reactivation, while a combination of NaB or TSA plus memory reactivation (or additional training) was necessary for the effective reinstatement of the ZIP-impaired memory. Additionally, NaB injections significantly facilitated development of long-term memory in animals with weak memory, while no effect was observed in animals with strong memory. The data obtained confirmed the assumption that histone acetylation is a critical regulatory component of memory development and reinstatement.
引用
收藏
页码:639 / 649
页数:10
相关论文
共 50 条
  • [41] Heterocyclic ketones as inhibitors of histone deacetylase
    Vasudevan, A
    Li, ZQ
    Frey, RR
    Wada, CK
    Steinman, D
    Heyman, HR
    Guo, Y
    Curtin, ML
    Guo, J
    Li, JL
    Pease, L
    Glaser, KB
    Marcotte, PA
    Bouska, JJ
    Davidsen, SK
    Michaelides, MR
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (22) : 3909 - 3913
  • [42] Histone Deacetylase Inhibitors and Bladder Cancer
    Adam, Rosalyn M.
    JOURNAL OF UROLOGY, 2010, 183 (06): : 2120 - 2121
  • [43] Acetylation and histone deacetylase inhibitors in cancer
    Kortenhorst, Madeleine S. Q.
    Carducci, Michael A.
    Shabbeer, Shabana
    CELLULAR ONCOLOGY, 2006, 28 (5-6) : 191 - 222
  • [44] Histone Deacetylase Inhibitors in Cancer Therapy
    Lane, Andrew A.
    Chabner, Bruce A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (32) : 5459 - 5468
  • [45] Histone Deacetylase Inhibitors in Myelodysplastic Syndrome
    Selene, Insija Ilyas
    Jose, Jemin Aby
    Sardar, Muhammad
    Shah, Zunairah
    Shafqat, Madeeha
    Faridi, Warda
    Malik, Mustafa Nadeem
    Yasir, Muhammad
    Khalil, Muhammad Jahanzeb
    Aslam, Shehroz
    Qureshi, Anum
    Rafiyath, Shamudeen
    Anwer, Faiz
    BLOOD, 2018, 132
  • [46] Histone deacetylase inhibitors in Hodgkin lymphoma
    Buglio, Daniela
    Younes, Anas
    INVESTIGATIONAL NEW DRUGS, 2010, 28 : S21 - S27
  • [47] Histone deacetylase inhibitors and genomic instability
    Eot-Houllier, Gregory
    Fulcrand, Geraldine
    Magnaghi-Jaulin, Laura
    Jaulin, Christian
    CANCER LETTERS, 2009, 274 (02) : 169 - 176
  • [48] Histone deacetylase inhibitors in cancer therapy
    Fouladi, Maryam
    CANCER INVESTIGATION, 2006, 24 (05) : 521 - 527
  • [49] Histone Deacetylase Inhibitors in the Treatment of Lymphoma
    Lemoine, Manuela
    Younes, Anas
    DISCOVERY MEDICINE, 2010, 10 (54) : 462 - 470
  • [50] New patented histone deacetylase inhibitors
    Wang, Haishan
    Dymock, Brian W.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2009, 19 (12) : 1727 - 1757